Security key
46435U192
- Type / Class
- Equity / GENOMICS IMMUN
- Total 13F shares
- 1,425,998
- Share change
- +319,706
- Total reported value
- $70,061,995
- Price per share
- $45.94
- Number of holders
- 63
- Value change
- +$15,568,071
- Number of buys
- 37
- Number of sells
- 14
Report period
Q4 2020
Institutions
63
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 46435U192
Recent filing periods:
Top shareholders of IDNA - ISHARES TR - GENOMICS IMMUN (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2020
As of 31 Dec 2020,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,425,998 shares.
The largest 10 holders included
Thrivent Financial for Lutherans, UBS Group AG, RETIREMENT CAPITAL STRATEGIES, LPL Financial LLC, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, Wealthcare Advisory Partners LLC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., STRATEGIC WEALTH MANAGEMENT INC, and STIFEL FINANCIAL CORP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
47
Q4 2020 holders
63
Holder diff
16
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.